LeukemiaCancer BiologyPeer-reviewed journal article
The Splicing Factor PTBP1 interacts with RUNX1 and is Required for Leukemia Cell Survival
Arjun DhiriD, Alexander EthelliD, Riley Watkins, Calvin K. LamiD, Kevin Tur-Rodriguez, Jimmie Persinger, Kasidy K. Dobish, Sipra PandaiD, Shannon M. BuckleyiD, Samantha A. SwensoniD, Sandipan BrahmaiD, M. Jordan RowleyiD, R. Katherine HydeiD
Abstract
Runt-related Transcription Factor 1 (RUNX1) is essential for definitive hematopoiesis and is among the most frequently mutated genes in leukemia. Previous work from our lab demonstrated that Histone Deacetylase 1 (HDAC1), a known RUNX1 partner, is unexpectedly required for active transcription suggesting a non-histone role for HDAC1 regulating components of the RUNX1 complex. Here, we use proteomics, genomics, and long-read transcriptomics to identify novel RUNX1 interacting partners and decipher their role in gene regulation and RNA splicing in leukemia cells. We demonstrate that Polypyrimidine Tract Binding Protein 1 (PTBP1) interacts with RUNX1 in an HDAC1 dependent manner. Chromatin profiling revealed extensive genome-wide overlap in sites occupied by RUNX1 and PTBP1, with significant enrichment at promoters of actively transcribed genes. Loss of PTBP1 in AML cells led to widespread alterations in RNA splicing and decreased expression of genes whose promoters are bound by both factors, including metabolic genes. In agreement with these findings, we found that loss of PTBP1 reduced glycolysis and glucose uptake and ultimately caused cell death. Based on our data, we propose that the interaction between RUNX1 and PTBP1 facilitates expression of metabolic proteins essential for leukemia cell growth and survival. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=92 SRC="FIGDIR/small/654547v1_ufig1.gif" ALT="Figure 1"> View larger version (20K): org.highwire.dtl.DTLVardef@74e3b9org.highwire.dtl.DTLVardef@12a090org.highwire.dtl.DTLVardef@eb5a48org.highwire.dtl.DTLVardef@17465dc_HPS_FORMAT_FIGEXP M_FIG C_FIG KEY POINTSO_LIPTBP1 binds RUNX1 in a HDAC1-dependent manner and co-localizes to the promoters of target genes in leukemia cells. C_LIO_LILoss of PTBP1 decreases expression of key metabolic genes, resulting in decreased cell growth and glycolysis, increased sensitivity to chemotherapy, and cell death. C_LI
- organism: human
- assay: scRNA-seq
- assay: long-read sequencing
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 2
- FWCI
- 1.48
- Field percentile
- top 15%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- RUNX1/RUNX1T1 controls alternative splicing in the t(8;21)-positive acute myeloid leukemia cells
V. Grinev, I. Ilyushonak, … O. Heidenreich·bioRxiv·May 4, 2019
- A PTBP1-CDC42 splicing axis regulates leukemia growth and venetoclax sensitivity in acute myeloid leukemia
Margaux Oberling, Mathieu Landry, … Margherita Ghisi·bioRxiv·Aug 26, 2026
- Myeloid lncRNA LOUP Mediates Opposing Regulatory Effects of RUNX1 and RUNX1-ETO in t(8;21) AML
B. Q. Trinh, S. Ummarino, … D. G. Tenen·bioRxiv·Jul 24, 2020
- Cell cycle corruption in a preleukemic ETV6-RUNX1 model exposes RUNX1 addiction as a therapeutic target in acute lymphoblastic leukemia
J. P. Wray, E. M. Deltcheva, … T. Enver·bioRxiv·Dec 22, 2020
- RUNX1 aberrations in blast-phase CML induce the RBP SPATS2L which promotes growth, survival and stress granule assembly
David A. Palmer, Amy Lianne Muir, … Rhys G Morgan·bioRxiv·Mar 30, 2026
- DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes
Fadimana Kaya, Findlay Bewicke‐Copley, … Ana Rio‐Machín·LeukemiaPeer-reviewed·Apr 9, 2025